Welcome to our dedicated page for CREDO TECHNOLOGY GROUP HOLDING SEC filings (Ticker: CRDO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Debugging 400G SerDes margins or tracking wafer supply clauses in Credo’s disclosures can consume hours. Each CRDO report packs dense semiconductor jargon, multi-jurisdictional risk factors, and complex royalty tables. If you’ve searched for “Credo Technology insider trading Form 4 transactions” or wondered how to interpret the next “Credo Technology quarterly earnings report 10-Q filing,” you know the challenge.
Stock Titan solves it. Our AI reads every submission the moment it hits EDGAR, then delivers plain-English answers to the queries investors actually type—“understanding Credo Technology SEC documents with AI,” “Credo Technology annual report 10-K simplified,” or “Credo Technology 8-K material events explained.” Dynamic summaries spotlight where SerDes licensing lifts gross margin, flag covenant changes, and link directly to supporting page numbers. Need immediate alerts? “Credo Technology Form 4 insider transactions real-time” are streamed within seconds so you can monitor executive stock transactions before the market digests them.
Use the platform to:
- Compare segment revenue trends across consecutive 10-Qs and access Credo Technology earnings report filing analysis without spreadsheets.
- Review Credo Technology proxy statement executive compensation data to evaluate incentive alignment with hyperscale design-win milestones.
- Capture context on capital-intensive fab commitments via 8-K and S-3 filings.
Whether you’re screening “Credo Technology executive stock transactions Form 4” or dissecting power-efficiency claims buried in a 300-page 10-K, our expert commentary, AI-powered summaries, and real-time updates turn complex semiconductor filings into actionable insight—no advanced RF engineering degree required.
Credo Technology Group (NASDAQ:CRDO) Chief Technology Officer Cheng Chi Fung reported insider sales of 55,000 ordinary shares from the Cheng Huang Family Trust on June 23, 2025. The transactions were executed at weighted average prices ranging from $82.83 to $85.45 per share, conducted through a pre-established Rule 10b5-1 trading plan. Following the transactions, the trust retains 7,438,961 shares, while Fung directly holds 119,350 shares.
Credo Technology Group Holding Ltd (CRDO) – Form 144 filing
Walden Technology Ventures II LP has filed a Notice of Proposed Sale of Securities under Rule 144. The fund intends to sell 12,248 common shares of Credo Technology through Morgan Stanley Smith Barney, with an aggregate market value of US $1.14 million. The anticipated sale date is 25 June 2025 on the NASDAQ exchange. Credo’s total shares outstanding are listed at 169,801,216, making the proposed sale approximately 0.007 % of shares outstanding.
The filing also discloses seven prior sales over the past three months by the same limited partnership, totaling 484,297 shares and US $42.2 million in gross proceeds. Individual transactions ranged from 3,527 to 171,473 shares, with sale dates between 5 June 2025 and 24 June 2025.
No adverse information about Credo’s operations is referenced in the filing, and the seller affirms it is not in possession of undisclosed material information. The shares were originally acquired on 22 December 2020 via a private transaction with the issuer and were paid for in cash.
Key Takeaways:
- Additional planned insider sale follows a series of sizable recent disposals.
- Cumulative sales by Walden in the last quarter represent about 0.29 % of Credo’s shares outstanding.
- While individually small, continued selling may create a perception of supply overhang among investors.
Credo Technology Group Holding Ltd (NASDAQ: CRDO) has received a Form 144 filing indicating a planned disposition of 80,000 common shares.
Key details are as follows:
- Filer/Account holder: Walden Technology Ventures II LP (address in Grand Cayman).
- Broker: Morgan Stanley Smith Barney LLC, Executive Financial Services, New York, NY.
- Class: Common stock.
- Approximate sale date: 24 Jun 2025, on the NASDAQ exchange.
- Aggregate market value of planned sale: US$7,261,816, implying an indicative price of about US$90.77 per share.
- Shares outstanding: 169,801,216, so the planned sale equals roughly 0.05 % of CRDO’s total shares.
The filing also discloses that the shares were originally acquired directly from the issuer on 8 Dec 2017 (58,770 shares) and 22 Dec 2020 (21,230 shares) for cash consideration.
Recent trading activity: Over the last three months Walden Technology Ventures II LP has already sold 404,297 CRDO shares in five transactions, generating cumulative gross proceeds of roughly US$31.5 million. The largest single sale was 171,473 shares on 16 Jun 2025.
Because Rule 144 notices are intent to sell filings, the shares may or may not ultimately be sold, and no pricing information beyond the aggregate value is provided. The proposed volume is small relative to CRDO’s float, suggesting limited direct market impact, but continuing distributions by a venture-capital holder may be noteworthy to investors monitoring insider supply dynamics.
Credo Technology Group Holding (CRDO) filed a routine Form 4 reporting that Chief Legal Officer & Secretary James Laufman sold 5,000 ordinary shares on 06/20/2025 at an average price of $85.0701 each. After the transaction, Laufman directly owns 249,346 shares. No derivative transactions or additional sales were disclosed.
Credo Technology Group (CRDO) Director Lip Bu Tan reported significant insider trading activity on June 18, 2025. The director sold 54,297 ordinary shares at a weighted average price of $86.3824 per share (ranging from $86.06 to $86.80).
Following the transaction, Tan's beneficial ownership consists of:
- 559,428 shares held indirectly through Walden Technology Ventures Investments II, L.P., where he serves as Managing Director
- 133,583 shares held indirectly through the Lip-Bu Tan and Ysa Loo Trust
- 39,736 shares held indirectly through A&E Investment LLC
- 53,574 shares held directly
The transaction was executed pursuant to proper documentation, with the Form 4 filed by attorney-in-fact James Laufman on June 20, 2025.
Credo Technology Group Holding Ltd (CRDO) filed a Form 144 indicating that James L. Laufman intends to sell up to 5,000 common shares through Morgan Stanley Smith Barney on or about 20 Jun 2025. At the most recent market price, the proposed sale is valued at approximately $425,350. The issuer has 169.8 million shares outstanding, so the planned disposition represents far less than 0.01 % of total shares.
The filing also discloses that Laufman sold an additional 18,000 shares over the last three months (10,000 shares on 11 Jun 2025 for $715,352 and 8,000 shares on 14 Apr 2025 for $312,720), bringing total disclosed insider sales in the period to 23,000 shares worth roughly $1.45 million.
No purchase price, financing arrangements, or material adverse information are noted. Given the small scale relative to the company’s float, the transaction appears routine and is unlikely to have a material impact on CRDO’s capitalization or trading dynamics.
Tuya Inc. (NYSE: TUYA) filed a Form 6-K to report a routine change in the composition of its Board Nomination Committee effective 19 June 2025.
- Departure: Mr. Chen Liaohan stepped down as a committee member.
- Appointment: Ms. Zhang Yan joined the committee.
- The Nomination Committee now consists of: Ms. Zhang Yan, Mr. Qiu Changheng (Chairman), and Mr. Kuok Meng Xiong.
- The company simultaneously released the poll results of its 2025 Annual General Meeting as Exhibit 99.2; no financial information was included in the 6-K itself.
No earnings figures, transactions, or strategic announcements were disclosed. The filing is primarily a governance update with minimal direct financial impact.
Credo Technology Group Holding (NASDAQ: CRDO) filed a Form 4 disclosing that director Lip-Bu Tan, through Walden Technology Ventures Investments II L.P., sold a total of 171,473 ordinary shares on 16 June 2025 across four tranches at weighted-average prices ranging from $76.6506 to $79.1236.
The transactions generated approximately $13.3 million in gross proceeds and reduced Walden’s indirect holding from about 785,198 to 613,725 shares, a decline of roughly 22%. Tan also continues to hold 133,583 shares via the Lip-Bu Tan and Ysa Loo Trust, 39,736 shares through A&E Investment LLC, and 53,574 shares directly.
No derivatives were transacted and the filing does not indicate that the sales were executed under a Rule 10b5-1 trading plan. No other material changes or risk factors were disclosed.
Credo Technology Group Chief Technology Officer and Director Cheng Chi Fung reported multiple sales of ordinary shares on June 16, 2025, executed through a pre-established Rule 10b5-1 trading plan from September 6, 2024.
The transactions involved the following sales from the Cheng Huang Family Trust:
- 1,500 shares at average price of $76.60
- 3,996 shares at average price of $77.94
- 34,644 shares at average price of $78.73
- 14,860 shares at average price of $79.30
Following these transactions, Fung maintains 119,350 shares held directly and 7,493,961 shares held indirectly through the Cheng Huang Family Trust. The trust transactions were executed at various price ranges, with all sales occurring between $76.05 and $79.66 per share.
Credo Technology Group Holding Ltd (CRDO) has received a Form 144 filing from Walden Technology Ventures II LP, an affiliate shareholder, indicating its intention to sell 54,297 common shares through Morgan Stanley Smith Barney on or about 18 June 2025 on the NASDAQ. At the 6 June market price implied by the filing, the transaction is valued at approximately $4.69 million.
The filing also discloses that the same shareholder has already sold 350,000 common shares during the past three months for aggregate gross proceeds of $26.7 million. Combining the completed and proposed transactions, Walden’s total share disposition during the period would reach 404,297 shares, equivalent to roughly 0.24 % of CRDO’s 169.8 million shares outstanding. The shares being sold were originally acquired directly from the issuer on 8 December 2017 via a private transaction for cash.
Because Form 144 filings merely provide advance notice of potential sales and do not guarantee execution, actual market impact will depend on whether the sales occur and the prevailing trading liquidity. Nonetheless, continued divestment by a venture-capital backer can signal portfolio rebalancing or profit-taking and may exert modest selling pressure. Given the limited percentage of outstanding shares involved, dilution is not an issue, but the filing may influence short-term sentiment toward CRDO’s stock.